Scans

Tools

Home

Charts

Watchlist

Products

Dabur India Ltd

DABUR

NSE

₹378.50-1.69%19 Oct 2026

Reports

FMCG Personal Care

Dabur India Ltd

DABUR

NSE

₹378.50

-1.69%

19 Oct 2026

SOICxStockScans Reports

Ask AI

FMCG Personal Care

Indices

Business Overview: What the company does, in plain English.Growth Catalysts: The forward growth drivers and triggers.Guidance Report: Management guidance vs outcomes.Forensic Report: Accounting quality and red flags.Deep Dive Report: In-depth business analysis.

Dabur India is a 141-year-old Indian consumer goods company built on a single, enduring idea - taking the ancient science of Ayurveda and reimagining it through modern science to create everyday products that feel both trusted and contemporary. What began as a small Ayurvedic pharmacy in Calcutta in 1884 has grown into the world’s largest Ayurvedic and natural healthcare company, with a portfolio of over 400 products reaching households in more than 120 countries. The recurring approach that explains everything else is this: Dabur takes a deep consumer belief in natural and herbal remedies, backs it with scientific validation and modern formats, and then pushes those products through one of India’s widest distribution networks - 8.5 million stores - so that eight out of ten Indian households end up using at least one Dabur product.

Business segments

Three engines built on the same Ayurvedic and natural heritage - a domestic FMCG powerhouse spanning health, personal care, and foods, an international business manufacturing locally across eight countries, and a beauty retail chain that sells everyone else’s brands alongside its own.

1. India FMCG: where the trust of eight in ten households is built

A portfolio of billion-rupee Ayurvedic and natural brands - from Chyawanprash to Real juices - sold through the country’s second-largest distribution network, with a deliberate shift toward premium products and faster-growing rural and quick-commerce channels.

Three business units under one roof - the India FMCG business is organised into Consumer Care (Healthcare plus Home & Personal Care) and Foods & Beverages, with Healthcare contributing 28% of domestic revenue, HPC 51%, and F&B 21% in the most recent quarter.
Flagship brands carry the load - eight power brands including Dabur Red, Real, Dabur Chyawanprash, Dabur Honey, Hajmola, Dabur Amla, Odonil, and Vatika together contribute over 70% of revenues, giving the company concentrated brand strength that simplifies marketing and distribution.
A distribution moat that is hard to replicate - Dabur directly reaches 1.52 million retail outlets and indirectly covers a total of 8.5 million stores, making it the second most distributed FMCG company in India; in rural areas, a dedicated force of over 25,000 “Yoddhas” takes products to 132,000 villages.
Riding the herbal wave - the company’s “natural and herbal” proposition is its main differentiator, and it benefits from a structural tailwind: the herbal toothpaste segment, for instance, is growing at nearly twice the rate of non-herbal, and Dabur Red Paste is already the number one Ayurvedic toothpaste in states like Orissa, Karnataka, Andhra Pradesh, and Tamil Nadu.
Premiumisation and new channels fuel the next leg - digital-first brands have crossed ₹100 crore in turnover, e-commerce now contributes 9% of sales with quick commerce making up 70-75% of that, and innovations like Dabur Himalayan Shilajit Gold or A2 Cow Ghee are pushing the portfolio into higher price points.

2. International business: Ayurveda adapted for 120 countries

A geographically spread operation - from the Middle East to the Americas - that manufactures almost entirely overseas, earns over a quarter of group revenue, and leads hair-oil markets from Egypt to Saudi Arabia.

Local manufacturing, not Indian exports - less than 1% of international products are shipped from India; instead, Dabur runs factories in eight overseas locations, including a 70,000-tonne hub in the UAE that supplies more than 70 countries.
Dominant in hair care across the Middle East and Africa - Dabur holds a 70% market share in hair oils in Saudi Arabia and 42% in the UAE, where it is the leading hair-care company overall according to KANTAR.
A collection of regional strongholds - the international business splits into the Middle East (27% of international revenue), Africa (23%), Asia (19%), Europe (16%), and the Americas (15%); in Sub-Saharan Africa, the business grew 20% in the most recent quarter, while the US Namaste business, anchored by the ORS haircare brand ranked number six in the category, grew 6.2%.
Turkey is a personal-care factory for Europe - Hobi Kozmetik, the Turkish subsidiary, is the market leader in hair gel with a 48% share and manufactures over 212 personal-care products, exporting to more than 57 countries from its factory near Istanbul.

3. NewU beauty retail: a franchise-run chain that sells premium beauty, including its own brands

A 105-store chain across 55 cities, operated on a franchise-owned model, that stocks domestic and international cosmetics while building a private-label portfolio contributing nearly a quarter of sales.

A franchise model that keeps it asset-light - NewU stores are franchise-owned but company-operated, which means Dabur controls the customer experience without tying up capital in real estate.
Private labels build margin and loyalty - exclusive brands like Jaquline USA, Botanica, and London Notes account for around 22% of NewU’s total sales, and a loyalty programme has enrolled over three million members, giving the chain a direct line to repeat customers.
Omnichannel from the start - beyond the physical stores, NewU sells through its own website and online marketplaces, so the chain captures demand wherever customers choose to shop.

Group structure and partners

A listed Indian parent with promoter ownership of 66% operates through a web of domestic and international subsidiaries that contributed nearly 29% of consolidated revenue, with two notable moves underway: the amalgamation of an Ayurvedic hair-oil company and the launch of a venture arm for digital-first brands.

The parent and its domestic bets - Dabur India Ltd. is the listed entity, and its key Indian subsidiaries include H&B Stores (which runs NewU), a 51% stake in spice-maker Badshah Masala acquired in early 2023, and Sesa Care, an Ayurvedic hair-oil company being merged into Dabur through a share swap approved by shareholders in May 2026.
International holdings sit under an Isle of Man entity - Dabur International Ltd. acts as the investment holding company for step-down subsidiaries in the UAE, Egypt, Nigeria, South Africa, Turkey, the US, and elsewhere, with the UAE’s Naturelle LLC serving as the central manufacturing hub.
A venture platform for the next generation - Dabur Ventures, a ₹500 crore investment platform launched in FY26, made its first move with a ₹60 crore minority stake in RAS Beauty, a luxury skincare D2C brand, signalling an intent to partner with digital-first, new-age consumer businesses rather than build everything in-house.
A significant legal overhang in the US - subsidiaries Namaste Laboratories, Dermoviva Skin Essentials, and Dabur International are defendants in approximately 5,400 cases consolidated in a multi-district litigation in Illinois, where plaintiffs allege that hair-relaxer products caused ovarian and uterine cancer; the subsidiaries deny liability.

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Price

Charts

Documents

Edit Ratios

Mkt Cap

Market Capitalization

₹67,144Cr

Close Price

₹378.50

Industry

FMCG Personal Care

Price To Earnings

34.04

Price To Sales

4.95

Revenue

₹13,552Cr

Rev Gr TTM

Revenue Growth TTM

7.40%

PAT Gr TTM

PAT Growth TTM

10.96%

Upcoming Results on

4 Nov 2026

Consolidated

Standalone

Numbers

Percentage

Quarter	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	3,204	3,255	2,815	3,349	3,029	3,355	2,830	3,405	3,191	3,559	3,038	3,764
Growth YoY Revenue Growth YoY%	7.3	7.0	5.1	7.0	-5.5	3.1	0.6	1.7	5.4	6.1	7.3	10.6
Expenses ExpensesCr	2,543	2,587	2,348	2,694	2,476	2,673	2,403	2,737	2,603	2,825	2,576	3,023
Operating Profit Operating ProfitCr	661	668	467	655	553	682	427	668	588	734	462	741
OPM OPM%	20.6	20.5	16.6	19.6	18.2	20.3	15.1	19.6	18.4	20.6	15.2	19.7
Other Income Other IncomeCr	117	127	128	129	152	129	141	144	140	125	174	172
Interest Expense Interest ExpenseCr	28	36	35	33	47	44	39	35	40	31	40	37
Depreciation DepreciationCr	98	97	107	109	111	109	117	114	115	117	122	121
PBT PBTCr	651	661	453	642	546	658	412	663	573	711	474	756
Tax TaxCr	144	155	111	148	128	142	99	154	128	158	112	169
PAT PATCr	507	506	341	494	418	516	313	508	445	554	362	586
Growth YoY PAT Growth YoY%	3.3	6.3	16.6	8.3	-17.7	1.9	-8.3	2.8	6.5	7.3	15.8	15.3
NPM NPM%	15.8	15.6	12.1	14.8	13.8	15.4	11.1	14.9	13.9	15.6	11.9	15.6
EPS EPS₹	2.9	2.9	2.0	2.8	2.4	3.0	1.8	2.9	2.5	3.2	2.1	3.3

Quarter	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	3,204	3,255	2,815	3,349	3,029	3,355	2,830	3,405	3,191	3,559	3,038	3,764
Growth YoY Revenue Growth YoY%	7.3	7.0	5.1	7.0	-5.5	3.1	0.6	1.7	5.4	6.1	7.3	10.6
Expenses ExpensesCr	2,543	2,587	2,348	2,694	2,476	2,673	2,403	2,737	2,603	2,825	2,576	3,023
Operating Profit Operating ProfitCr	661	668	467	655	553	682	427	668	588	734	462	741
OPM OPM%	20.6	20.5	16.6	19.6	18.2	20.3	15.1	19.6	18.4	20.6	15.2	19.7
Other Income Other IncomeCr	117	127	128	129	152	129	141	144	140	125	174	172
Interest Expense Interest ExpenseCr	28	36	35	33	47	44	39	35	40	31	40	37
Depreciation DepreciationCr	98	97	107	109	111	109	117	114	115	117	122	121
PBT PBTCr	651	661	453	642	546	658	412	663	573	711	474	756
Tax TaxCr	144	155	111	148	128	142	99	154	128	158	112	169
PAT PATCr	507	506	341	494	418	516	313	508	445	554	362	586
Growth YoY PAT Growth YoY%	3.3	6.3	16.6	8.3	-17.7	1.9	-8.3	2.8	6.5	7.3	15.8	15.3
NPM NPM%	15.8	15.6	12.1	14.8	13.8	15.4	11.1	14.9	13.9	15.6	11.9	15.6
EPS EPS₹	2.9	2.9	2.0	2.8	2.4	3.0	1.8	2.9	2.5	3.2	2.1	3.3

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	7,869	7,614	7,722	8,515	8,685	9,562	10,889	11,530	12,404	12,563	13,193	13,552
Growth Revenue Growth%	0.5	-3.2	1.4	10.3	2.0	10.1	13.9	5.9	7.6	1.3	5.0	7.4
Expenses ExpensesCr	6,350	6,105	6,104	6,775	6,892	7,559	8,635	9,366	10,004	10,247	10,741	11,027
Operating Profit Operating ProfitCr	1,518	1,509	1,617	1,740	1,792	2,003	2,254	2,164	2,400	2,316	2,452	2,525
OPM OPM%	19.3	19.8	20.9	20.4	20.6	20.9	20.7	18.8	19.4	18.4	18.6	18.6
Other Income Other IncomeCr	217	299	291	222	205	324	306	444	482	551	583	611
Interest Expense Interest ExpenseCr	48	54	53	60	50	31	39	78	124	164	145	147
Depreciation DepreciationCr	133	143	162	177	220	240	253	311	399	446	469	476
PBT PBTCr	1,554	1,611	1,693	1,725	1,728	2,056	2,269	2,219	2,359	2,258	2,420	2,513
Tax TaxCr	300	330	335	279	280	361	526	517	547	517	552	567
PAT PATCr	1,254	1,280	1,358	1,446	1,448	1,695	1,742	1,701	1,811	1,740	1,869	1,947
Growth PAT Growth%	17.4	2.1	6.0	6.5	0.1	17.1	2.8	-2.4	6.5	-3.9	7.4	11.0
NPM NPM%	15.9	16.8	17.6	17.0	16.7	17.7	16.0	14.8	14.6	13.8	14.2	14.4
EPS EPS₹	7.1	7.3	7.7	8.2	8.2	9.6	9.8	9.6	10.4	10.0	10.7	11.1

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	7,869	7,614	7,722	8,515	8,685	9,562	10,889	11,530	12,404	12,563	13,193	13,552
Growth Revenue Growth%	0.5	-3.2	1.4	10.3	2.0	10.1	13.9	5.9	7.6	1.3	5.0	7.4
Expenses ExpensesCr	6,350	6,105	6,104	6,775	6,892	7,559	8,635	9,366	10,004	10,247	10,741	11,027
Operating Profit Operating ProfitCr	1,518	1,509	1,617	1,740	1,792	2,003	2,254	2,164	2,400	2,316	2,452	2,525
OPM OPM%	19.3	19.8	20.9	20.4	20.6	20.9	20.7	18.8	19.4	18.4	18.6	18.6
Other Income Other IncomeCr	217	299	291	222	205	324	306	444	482	551	583	611
Interest Expense Interest ExpenseCr	48	54	53	60	50	31	39	78	124	164	145	147
Depreciation DepreciationCr	133	143	162	177	220	240	253	311	399	446	469	476
PBT PBTCr	1,554	1,611	1,693	1,725	1,728	2,056	2,269	2,219	2,359	2,258	2,420	2,513
Tax TaxCr	300	330	335	279	280	361	526	517	547	517	552	567
PAT PATCr	1,254	1,280	1,358	1,446	1,448	1,695	1,742	1,701	1,811	1,740	1,869	1,947
Growth PAT Growth%	17.4	2.1	6.0	6.5	0.1	17.1	2.8	-2.4	6.5	-3.9	7.4	11.0
NPM NPM%	15.9	16.8	17.6	17.0	16.7	17.7	16.0	14.8	14.6	13.8	14.2	14.4
EPS EPS₹	7.1	7.3	7.7	8.2	8.2	9.6	9.8	9.6	10.4	10.0	10.7	11.1

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	176	176	176	177	177	177	177	177	177	177	177
Reserves ReservesCr	3,995	4,671	5,530	5,455	6,429	7,487	8,205	8,796	9,689	10,623	11,242
Current Liabilities Current LiabilitiesCr	2,253	2,225	2,434	2,660	2,464	2,934	3,323	3,609	3,930	4,318	5,239
Non Current Liabilities Non Current LiabilitiesCr	487	636	534	113	248	213	540	604	889	704	438
Total Liabilities Total LiabilitiesCr	6,932	7,732	8,702	8,437	9,354	10,847	12,285	13,654	15,123	16,232	17,480
Current Assets Current AssetsCr	3,216	3,114	3,440	3,586	4,880	4,776	4,317	4,249	5,680	6,532	8,886
Non Current Assets Non Current AssetsCr	3,717	4,618	5,262	4,850	4,474	6,071	7,968	9,405	9,443	9,700	8,594
Total Assets Total AssetsCr	6,932	7,732	8,702	8,437	9,354	10,847	12,285	13,654	15,123	16,232	17,480

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	176	176	176	177	177	177	177	177	177	177	177
Reserves ReservesCr	3,995	4,671	5,530	5,455	6,429	7,487	8,205	8,796	9,689	10,623	11,242
Current Liabilities Current LiabilitiesCr	2,253	2,225	2,434	2,660	2,464	2,934	3,323	3,609	3,930	4,318	5,239
Non Current Liabilities Non Current LiabilitiesCr	487	636	534	113	248	213	540	604	889	704	438
Total Liabilities Total LiabilitiesCr	6,932	7,732	8,702	8,437	9,354	10,847	12,285	13,654	15,123	16,232	17,480
Current Assets Current AssetsCr	3,216	3,114	3,440	3,586	4,880	4,776	4,317	4,249	5,680	6,532	8,886
Non Current Assets Non Current AssetsCr	3,717	4,618	5,262	4,850	4,474	6,071	7,968	9,405	9,443	9,700	8,594
Total Assets Total AssetsCr	6,932	7,732	8,702	8,437	9,354	10,847	12,285	13,654	15,123	16,232	17,480

Consolidated

Standalone

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	1,187	1,227	1,092	1,499	1,614	2,115	1,802	1,488	2,013	1,987	2,579
Investing Cash Flow Investing Cash FlowCr	-730	-807	-540	337	-517	-1,406	-1,275	-587	-972	-449	-1,285
Financing Cash Flow Financing Cash FlowCr	-374	-339	-577	-1,888	-1,043	-613	-490	-1,035	-1,161	-1,405	-1,236
Net Cash Flow Net Cash FlowCr	82	81	-26	-52	54	95	36	-133	-119	132	58
Free Cash Flow Free Cash FlowCr	998	741	891	1,274	1,213	1,808	1,433	1,003	1,453	1,448	2,180
CFO To PAT CFO To PAT%	94.7	95.8	80.4	103.7	111.4	124.8	103.5	87.5	111.2	114.2	138.0
CFO To EBITDA CFO To EBITDA%	78.2	81.3	67.5	86.2	90.0	105.6	80.0	68.8	83.9	85.8	105.2

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	1,187	1,227	1,092	1,499	1,614	2,115	1,802	1,488	2,013	1,987	2,579
Investing Cash Flow Investing Cash FlowCr	-730	-807	-540	337	-517	-1,406	-1,275	-587	-972	-449	-1,285
Financing Cash Flow Financing Cash FlowCr	-374	-339	-577	-1,888	-1,043	-613	-490	-1,035	-1,161	-1,405	-1,236
Net Cash Flow Net Cash FlowCr	82	81	-26	-52	54	95	36	-133	-119	132	58
Free Cash Flow Free Cash FlowCr	998	741	891	1,274	1,213	1,808	1,433	1,003	1,453	1,448	2,180
CFO To PAT CFO To PAT%	94.7	95.8	80.4	103.7	111.4	124.8	103.5	87.5	111.2	114.2	138.0
CFO To EBITDA CFO To EBITDA%	78.2	81.3	67.5	86.2	90.0	105.6	80.0	68.8	83.9	85.8	105.2

Consolidated

Standalone

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr	43,829	48,821	57,602	72,250	79,562	95,565	94,854	96,579	92,704	89,777	72,792	67,144
Price To Earnings Price To Earnings	35.0	38.2	42.5	50.1	55.0	56.4	54.5	56.5	50.3	50.8	38.4	34.0
Price To Sales Price To Sales	5.6	6.4	7.5	8.5	9.2	10.0	8.7	8.4	7.5	7.2	5.5	5.0
Price To Book Price To Book	10.5	10.1	10.1	12.8	12.1	12.5	11.3	10.8	9.4	8.3	6.4	5.9
EV To EBITDA EV To EBITDA	29.2	32.8	35.9	41.6	44.2	47.3	42.3	45.0	38.9	38.9	30.0	27.3
Profitability Ratios Profitability Ratios
GPM GPM%	49.6	47.8	47.9	47.0	47.4	47.6	45.7	42.7	45.4	45.3	45.7	45.7
OPM OPM%	19.3	19.8	20.9	20.4	20.6	20.9	20.7	18.8	19.4	18.4	18.6	18.6
NPM NPM%	15.9	16.8	17.6	17.0	16.7	17.7	16.0	14.8	14.6	13.8	14.2	14.4
ROCE ROCE%	32.3	28.9	26.7	29.0	25.1	25.5	24.5	22.6	22.1	20.6	20.2	20.2
ROE ROE%	30.1	26.4	23.8	25.7	21.9	22.1	20.8	19.0	18.4	16.1	16.4	16.4
ROA ROA%	18.1	16.6	15.6	17.1	15.5	15.6	14.2	12.5	12.0	10.7	10.7	10.7
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr	43,829	48,821	57,602	72,250	79,562	95,565	94,854	96,579	92,704	89,777	72,792	67,144
Price To Earnings Price To Earnings	35.0	38.2	42.5	50.1	55.0	56.4	54.5	56.5	50.3	50.8	38.4	34.0
Price To Sales Price To Sales	5.6	6.4	7.5	8.5	9.2	10.0	8.7	8.4	7.5	7.2	5.5	5.0
Price To Book Price To Book	10.5	10.1	10.1	12.8	12.1	12.5	11.3	10.8	9.4	8.3	6.4	5.9
EV To EBITDA EV To EBITDA	29.2	32.8	35.9	41.6	44.2	47.3	42.3	45.0	38.9	38.9	30.0	27.3
Profitability Ratios Profitability Ratios
GPM GPM%	49.6	47.8	47.9	47.0	47.4	47.6	45.7	42.7	45.4	45.3	45.7	45.7
OPM OPM%	19.3	19.8	20.9	20.4	20.6	20.9	20.7	18.8	19.4	18.4	18.6	18.6
NPM NPM%	15.9	16.8	17.6	17.0	16.7	17.7	16.0	14.8	14.6	13.8	14.2	14.4
ROCE ROCE%	32.3	28.9	26.7	29.0	25.1	25.5	24.5	22.6	22.1	20.6	20.2	20.2
ROE ROE%	30.1	26.4	23.8	25.7	21.9	22.1	20.8	19.0	18.4	16.1	16.4	16.4
ROA ROA%	18.1	16.6	15.6	17.1	15.5	15.6	14.2	12.5	12.0	10.7	10.7	10.7
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

	HINDUNILVR	MARICO	GODREJCP	DABUR	COLPAL	GILLETTE	PGHH
Market CapitalizationMkt CapCr	4,35,426	1,01,156	86,674	67,144	47,355	23,670	23,205
Close PriceClose₹	1,853.20	778.00	847.00	378.50	1,741.10	7,264.00	7,148.50
IndustryIndustry	FMCG Personal Care	FMCG Personal Care	FMCG Personal Care	FMCG Personal Care	FMCG Personal Care	FMCG Personal Care	FMCG Personal Care
Price To EarningsPE	29.20	53.32	45.27	34.04	35.14	35.43	29.35
Price To SalesPS	6.59	7.09	5.43	4.95	7.63	7.45	5.47
RevenueRevenueCr	66,052	14,277	15,949	13,552	6,204	3,176	4,245
Revenue Growth TTMRev Gr TTM%	5.8%	25.1%	9.2%	7.4%	3.8%	8.0%	-1.5%
PAT Growth TTMPAT Gr TTM%	38.3%	15.0%	3.2%	11.0%	-3.3%	18.6%	-4.6%

	HINDUNILVR	MARICO	GODREJCP	DABUR	COLPAL	GILLETTE	PGHH
Market CapitalizationMkt CapCr	4,35,426	1,01,156	86,674	67,144	47,355	23,670	23,205
Close PriceClose₹	1,853.20	778.00	847.00	378.50	1,741.10	7,264.00	7,148.50
IndustryIndustry	FMCG Personal Care	FMCG Personal Care	FMCG Personal Care	FMCG Personal Care	FMCG Personal Care	FMCG Personal Care	FMCG Personal Care
Price To EarningsPE	29.20	53.32	45.27	34.04	35.14	35.43	29.35
Price To SalesPS	6.59	7.09	5.43	4.95	7.63	7.45	5.47
RevenueRevenueCr	66,052	14,277	15,949	13,552	6,204	3,176	4,245
Revenue Growth TTMRev Gr TTM%	5.8%	25.1%	9.2%	7.4%	3.8%	8.0%	-1.5%
PAT Growth TTMPAT Gr TTM%	38.3%	15.0%	3.2%	11.0%	-3.3%	18.6%	-4.6%